RecruitingNCT03971487

Ocrelizumab for Psychosis by Autoimmunity

This study is recruiting. It focuses on schizophrenia and currently lists participation information in the United States.

SchizophreniaOtherFrom 18 Years to 35 Years

In plain English

Key information made simple

This study exists to compare options and see whether this type of care offers something meaningfully different. Researchers are trying to understand what this type of care can reveal about signals in the brain or body that may guide care later on. For people living with Schizophrenia, the gap between what sounds good on paper and what works in daily life is often important. If the findings are useful, they could help future care become more targeted, practical, and easier to trust. Taking part helps build the evidence that can improve understanding and care for others over time.

What to expect

Your next step

The official record suggests in-person participation through a research setting, with sites including Houston Methodist Research Institute. Participation appears to involve guided sessions or support activities with check-ins on how they fit into daily life. The main fit is usually matching the main diagnosis and being able to understand the study and consent, while common reasons not to take part include major medical issues that could make participation unsuitable and active substance or alcohol problems that could affect the results. This is an early-stage study, which usually means a smaller group and a focus on learning how the approach behaves.

Official source

Registry reference

This page links back to the public source record so people can verify details directly with the registry and research team.

If you want the full study description, eligibility criteria, locations, and sponsor information in the original format, this is the place to check before taking the next step.

Open source record

Need help deciding?

Ask HopeStage to review this study with me

This form records your interest so HopeStage can follow up with practical guidance. It is not a medical eligibility decision and it does not guarantee a study spot.

Study reference: NCT03971487. We only ask for your email here. HopeStage can help you review the study, but this is not a medical eligibility decision.

In practice

For you

Taking part may help improve understanding of your condition.

It requires regular follow-up, often through questionnaires or interviews.

Requires travel, with in-person participation in United States.

Important

Not medical advice

Information from public sources. Are you the study sponsor? Contact us to update this page: hi@hopestage.com

Study clarity

Things to check before joining

Sponsor: The Methodist Hospital Research Institute
Sponsor type: Hospital / academic medical center
Main activity: unknown
Time commitment: long follow-up or multiple visits
Study phase: Not available
Enrollment: Not available
Recruitment status: Recruiting
Source: Official registry link

FAQ

Questions about this study

What is Ocrelizumab for Psychosis by Autoimmunity?

This study is exploring a mental health research question for people with schizophrenia. The research team can explain what participation involves. Direct benefit is not guaranteed.

Who is behind this study, and what type of sponsor is it?

This study is sponsored by The Methodist Hospital Research Institute. Based on the sponsor name or official registry information, it appears to be a hospital or academic medical center. You should verify the details in the official registry record.

What does participation involve, what phase is it, and what should I ask about safety?

This study may involve unknown, study visits, and assessments. The time commitment is long follow-up or multiple visits. The study phase is not available in HopeStage data. Check the official source record to see whether a phase is listed. Enrollment is not available in HopeStage data. HopeStage cannot say whether a study is safe or right for you. Before joining, ask the research team about possible risks, time commitment, visits, side effects, compensation, safety monitoring, and whether participation may affect your current care.

Where can I verify the study details?

Use the official source record linked on this page to check the full study description, recruitment status, eligibility criteria, locations, sponsor information, phase, enrollment, contact details, and any listed risks or requirements.